Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.

NCT03520348 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye
Dry Eye Syndrome of Unspecified Lacrimal Gland

Interventions

DRUG: PRO-167
DRUG: Corneregel

Sponsor

Laboratorios Sophia S.A de C.V.